Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000530966 | SCV000643958 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002367874 | SCV002661475 | uncertain significance | Cardiovascular phenotype | 2020-08-19 | criteria provided, single submitter | clinical testing | The p.I23066T variant (also known as c.69197T>C), located in coding exon 174 of the TTN gene, results from a T to C substitution at nucleotide position 69197. The isoleucine at codon 23066 is replaced by threonine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |